DZ Bank Reaffirms Buy Rating for Evonik Industries (EVK)

DZ Bank reissued their buy rating on shares of Evonik Industries (FRA:EVK) in a research note published on Wednesday.

Other analysts also recently issued reports about the company. Societe Generale set a €36.00 ($44.44) price objective on Evonik Industries and gave the company a buy rating in a research note on Friday, November 3rd. Commerzbank set a €33.00 ($40.74) price objective on Evonik Industries and gave the company a buy rating in a research note on Friday, November 3rd. Baader Bank set a €38.00 ($46.91) price objective on Evonik Industries and gave the company a buy rating in a research note on Friday, November 3rd. Sanford C. Bernstein set a €35.00 ($43.21) price objective on Evonik Industries and gave the company a buy rating in a research note on Friday, November 3rd. Finally, Barclays set a €35.50 ($43.83) price objective on Evonik Industries and gave the company a buy rating in a research note on Monday, November 6th. Three analysts have rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of €34.00 ($41.98).

Shares of Evonik Industries (EVK) opened at €30.07 ($37.12) on Wednesday. The company has a market capitalization of $13,970.00 and a P/E ratio of 19.15. Evonik Industries has a one year low of €26.78 ($33.06) and a one year high of €32.97 ($40.70).

ILLEGAL ACTIVITY NOTICE: “DZ Bank Reaffirms Buy Rating for Evonik Industries (EVK)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/17/dz-bank-reaffirms-buy-rating-for-evonik-industries-evk.html.

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply